Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B

被引:2
|
作者
Park, Yewan [1 ,2 ]
Kang, Danbee [3 ,4 ]
Sinn, Dong Hyun [2 ,5 ]
Kim, Hyunsoo [4 ]
Hong, Yun Soo [6 ,7 ]
Cho, Juhee [3 ,4 ,6 ,7 ]
Gwak, Geum-Youn [5 ]
机构
[1] Kyung Hee Univ Hosp, Dept Internal Med, Seoul 02447, South Korea
[2] Sungkyunkwan Univ, Dept Digital Hlth, SAIHST, Seoul 06355, South Korea
[3] Sungkyunkwan Univ, Dept Clin Res Design & Evaluat, SAIHST, Seoul 06355, South Korea
[4] Sungkyunkwan Univ, Ctr Clin Epidemiol, Samsung Med Ctr, Seoul 06351, South Korea
[5] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul 06351, South Korea
[6] Johns Hopkins Med Inst, Dept Epidemiol & Med, Baltimore, MD 21287 USA
[7] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA
关键词
Lifestyle modification; Chronic hepatitis B; Hepatocellular carcinoma; Cancer; Mortality; CHRONIC VIRAL-HEPATITIS; COFFEE CONSUMPTION; CIGARETTE-SMOKING; LIVER-CANCER; ALCOHOL; RISK; INFECTION; DRINKING; TOBACCO;
D O I
10.3748/wjg.v29.i24.3843
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Research exploring the influence of healthier lifestyle modification (LSM) on the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is limited. AIM To emulate a target trial to determine the effect of LSM on HCC incidence and mortality among patients with CHB by large-scale population-based observational data. METHODS Among the patients with CHB enrolled in the Korean National Health Insurance Service between January 1, 2009, and December 31, 2017, those aged >= 20 years who drank alcohol, smoked cigarettes, and were sedentary were analyzed. Exposure included at least one LSM, including alcohol abstinence, smoking cessation, and regular exercise. The primary outcome was HCC development, and the secondary outcome was liver-related mortality. We used 2:1 propensity score matching to account for covariates. RESULTS With 48766 patients in the LSM group and 103560 in the control group, the adjusted hazard ratio (HR) for incident HCC and liver-related mortality was 0.92 [95% confidence interval (CI): 0.87-0.96] and 0.92 (95%CI: 0.86-0.99) in the LSM group, respectively, compared with the control group. Among the LSM group, the adjusted HR (95%CI) for incident HCC was 0.84 (0.76-0.94), 0.87 (0.81-0.94), and 1.08 (1.00-1.16) for alcohol abstinence, smoking cessation, and regular exercise, respectively. The adjusted HR (95%CI) for liver-related mortality was 0.92 (0.80-1.06), 0.81 (0.72-0.91), and 1.15 (1.04-1.27) for alcohol abstinence, smoking cessation, and regular exercise, respectively. CONCLUSION LSM lowered the risk of HCC and mortality in patients with CHB. Thus, active LSM, particularly alcohol abstinence and smoking cessation, should be encouraged in patients with CHB. (c) The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:3843 / 3854
页数:12
相关论文
共 50 条
  • [1] Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
    Yewan Park
    Danbee Kang
    Dong Hyun Sinn
    Hyunsoo Kim
    Yun Soo Hong
    Juhee Cho
    Geum-Youn Gwak
    World Journal of Gastroenterology, 2023, (24) : 3843 - 3854
  • [2] Risk of hepatocellular carcinoma and mortality among treated patients with chronic hepatitis B versus chronic hepatitis C
    Kim, Gi-Ae
    Lim, Young-Suk
    An, Jihyun
    Park, Jin-A
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 383 - 383
  • [3] Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C.
    Kasahara, A
    Hayashi, N
    Sasaki, Y
    Kakumu, S
    Kiyosawa, K
    Okita, K
    HEPATOLOGY, 2000, 32 (04) : 361A - 361A
  • [4] Entecavir reduces the incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Yasunaka, Tetsuya
    Ikeda, Fusao
    Takaki, Akinobu
    Seno, Tomonori
    Takaguchi, Koichi
    Yamamoto, Kazuhide
    HEPATOLOGY, 2014, 60 : 1096A - 1096A
  • [5] Incidence of hepatocellular carcinoma in chronic infection with hepatitis B
    Ntagirabiri, Renovat
    Munezero, Belyse
    Kaze, Hippolyte
    Ndirahisha, Eugene
    Manirakiza, Sebastien
    PAN AFRICAN MEDICAL JOURNAL, 2015, 20
  • [6] Effect of interferon on incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Soga, K
    Shibasaki, K
    Aoyagi, Y
    HEPATO-GASTROENTEROLOGY, 2005, 52 (64) : 1154 - 1158
  • [7] Predictive Factors Associated with Hepatocellular Carcinoma Incidence and Mortality after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    HEPATOLOGY, 2018, 68 : 133A - 134A
  • [8] Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase
    Mak, Lung-Yi
    Yee, Leland J.
    Wong, Robert J.
    Ramers, Christian B.
    Frenette, Catherine
    Hsu, Yao-Chun
    JOURNAL OF VIRAL HEPATITIS, 2024, 31 : 27 - 35
  • [9] Risk of Hepatocellular Carcinoma Among Treated Patients With Chronic Hepatitis B vs Chronic Hepatitis C
    Kim, Gi-Ae
    Han, Seungbong
    An, Jihyun
    Lim, Young-Suk
    HEPATOLOGY, 2014, 60 : 1092A - 1092A
  • [10] Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
    Lim, Young-Suk
    Han, Seungbong
    Heo, Nae-Yun
    Shim, Ju Hyun
    Lee, Han Chu
    Suh, Dong Jin
    GASTROENTEROLOGY, 2014, 147 (01) : 152 - 161